ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      87.025
      0.13%
      Bitcoin
      57,289.36
      -4.78%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. FibroGen Inc (FGEN)

      7. FibroGen Inc (FGEN) News

      FGEN

      FibroGen (FGEN)

      FibroGen Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:FGEN
      DateTimeSourceHeadlineSymbolCompany
      02/10/20228:14AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FGENFibroGen Inc
      02/04/20227:00AMGlobeNewswire Inc.FibroGen to Present at SVB Leerink 11th Annual Global Healthcare ConferenceNASDAQ:FGENFibroGen Inc
      02/01/20225:16PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FGENFibroGen Inc
      01/28/20221:11PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FGENFibroGen Inc
      01/07/20225:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      01/05/20224:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      01/05/20224:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      01/04/20227:00AMGlobeNewswire Inc.FibroGen to Present at H.C. Wainwright Bioconnect Virtual ConferenceNASDAQ:FGENFibroGen Inc
      12/23/20215:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      12/20/20218:00AMGlobeNewswire Inc.FibroGen Exercises Exclusive License Option for HiFiBiO’s CCR8 ProgramNASDAQ:FGENFibroGen Inc
      12/08/20214:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      12/03/20214:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      11/09/20215:26PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FGENFibroGen Inc
      11/09/20214:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FGENFibroGen Inc
      11/09/20214:01PMGlobeNewswire Inc.FibroGen Reports Third Quarter 2021 Financial ResultsNASDAQ:FGENFibroGen Inc
      11/02/20217:00AMGlobeNewswire Inc.FibroGen to Present at Upcoming Investor ConferencesNASDAQ:FGENFibroGen Inc
      10/26/20217:00AMGlobeNewswire Inc.FibroGen to Report Third Quarter 2021 Financial ResultsNASDAQ:FGENFibroGen Inc
      10/25/20217:00AMGlobeNewswire Inc.FibroGen Announces Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week 2021NASDAQ:FGENFibroGen Inc
      10/06/20217:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      09/24/20214:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      08/25/20217:00AMGlobeNewswire Inc.FibroGen Announces Positive Topline Results from Phase 2 Clinical Trial of Roxadustat for the Treatment of Chemotherapy Induced AnemiaNASDAQ:FGENFibroGen Inc
      08/20/20216:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FGENFibroGen Inc
      08/19/20217:35PMGlobeNewswire Inc.Astellas Receives European Commission Approval for First-in-Class EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney DiseaseNASDAQ:FGENFibroGen Inc
      08/19/20217:30PMPR Newswire (US)Astellas Receives European Commission Approval for First-in-Class EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney DiseaseNASDAQ:FGENFibroGen Inc
      08/16/20217:00AMGlobeNewswire Inc.FibroGen Announces Retirement of Pat Cotroneo and Appointment of Juan Graham as Chief Financial OfficerNASDAQ:FGENFibroGen Inc
      08/11/202110:15AMDow Jones NewsAstraZeneca Says US FDA Calls for Extra Clinical Trial on Safety of RoxadustatNASDAQ:FGENFibroGen Inc
      08/11/20218:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FGENFibroGen Inc
      08/11/20217:54AMDow Jones NewsFDA Rejects FibroGen's Roxadustat for Anemia of Chronic Kidney DiseaseNASDAQ:FGENFibroGen Inc
      08/11/20217:00AMGlobeNewswire Inc.FibroGen Receives Complete Response Letter from the FDA for Roxadustat for Anemia of Chronic Kidney DiseaseNASDAQ:FGENFibroGen Inc
      08/10/202110:34AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FGENFibroGen Inc
       Showing the most relevant articles for your search:NASDAQ:FGEN

      Your Recent History

      BIT
      UB515U
      Unicredit Bank
      Delayed Upgrade Clock